CDKN2A and lung neuroendocrine neoplasm: However, univariate analyses including each histotype and the p16Ink4A status confirmed that p16Ink4A expression is an independent indicator of poor prognosis in neuroendocrine lung tumors (p ranging 0.001 to 0.01).